Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Sientra® to Release Third Quarter 2017 Financial Results


Posted on: 03 Nov 17

Host Conference Call on Tuesday, November 7, 2017

Management to Participate at Three Upcoming Investor Conferences

SANTA BARBARA, Calif., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its third quarter 2017 financial results on Tuesday, November 7, 2017 after market close.

Sientra will hold a conference call on Tuesday, November 7, 2017 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. A press release disclosing the Company's financial results will be distributed at approximately 1:00 p.m. PT/4:00 p.m. ET that same day.

The dial-in numbers are (844) 464-3933 for domestic callers and (765) 507-2612 for international callers. The conference ID is 6798858.  A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com.

A replay of the call will be available starting on November 7, 2017 at 4:30 p.m. PT/7:30 p.m. ET, through November 14, 2017 at 8:59 p.m. PT/11:59 p.m. ET.  To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers, and use the replay conference ID 6798858.  The webcast will be available on the Investor Relations section of the Company’s website for 30 days following the completion of the call.  

The Company also announced that Jeff Nugent, President and Chief Executive Officer, and Patrick F. Williams, Chief Financial Officer, are scheduled to participate at three upcoming investor conferences. The first conference is the Stephens Fall Investment Conference, which will include a fireside chat with management.

 

          
 Event:Stephens Fall Investment Conference                                                                     
 Date:Wednesday, November 8, 2017 
 Time:2:00 p.m. ET 
 Location: Lotte NY Palace Hotel, New York 
 

The second conference is the Canaccord Genuity 11th Annual Medical Technology & Diagnostics Forum. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.

       
 Event:Canaccord Genuity 11th Annual Medical Technology & Diagnostics Forum
 Date:Thursday, November 9, 2017
 Location:Westin Grand Central Hotel, New York
 

The third conference is the Stifel 2017 Healthcare Conference, which will include a presentation from management.

       
 Event:Stifel 2017 Healthcare Conference                                                         
 Date:Tuesday, November 14, 2017
 Time:8:45 a.m. ET
 Location:Lotte NY Palace Hotel, New York
   

Audio webcasts of the Company’s presentations at the Stephens and Stifel conferences will be made available on the investor relations section of Sientra’s web site at www.sientra.com. Replays of the presentations will be available for 90 days.

About Sientra

Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients' lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including BIOCORNEUM®, the professional choice in scar management, and miraDry®, the only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors.

For more information about Sientra, visit www.sientra.com.
Find Sientra on FacebookTwitterLinkedIn and Instagram

   

Investor Contacts:
Patrick F. Williams
Sientra, Chief Financial Officer
(619) 675-1047
patrick.williams@sientra.com 

Zack Kubow / Brian Johnston
The Ruth Group
(646) 536-7020 / (646) 536-7028
ir@sientra.com  

GlobeNewswire
globenewswire.com

Last updated on: 06/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.